Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer Table 1
收藏Taylor & Francis Group2024-05-15 更新2026-04-16 收录
下载链接：
https://tandf.figshare.com/articles/dataset/Efficacy_and_safety_of_immune_checkpoint_inhibitors_combined_with_recombinant_human_endostatin_and_chemotherapy_as_the_first-line_treatment_of_advanced_non-small-cell_lung_cancer_Table_1/22634656/1
下载链接
链接失效反馈官方服务：
资源简介：
Efficacy and safety of immune checkpoint inhibitors combined with recombinant human endostatin and chemotherapy as the first-line treatment of advanced non-small-cell lung cancer Table 1
免疫检查点抑制剂（immune checkpoint inhibitors）联合重组人内皮抑素与化疗用于晚期非小细胞肺癌一线治疗的疗效与安全性 表1
提供机构：
Tu, Ganjie; Liu, Yangyang; Shang, Kai; Lu, Zhihui; Chen, Li; Zhong, Peiyuan; Peng, Sujuan; Fu, Silv; Li, Siling; Zhu, Xie; Huang, Hongxiang
创建时间：
2023-04-14
